RECOVERY FROM EXPERIMENTAL PARKINSONISM IN PRIMATES WITH GM1 GANGLIOSIDE TREATMENT

被引:186
作者
SCHNEIDER, JS [1 ]
POPE, A [1 ]
SIMPSON, K [1 ]
TAGGART, J [1 ]
SMITH, MG [1 ]
DISTEFANO, L [1 ]
机构
[1] HAHNEMANN UNIV, SCH MED, INST NEUROSCI, PHILADELPHIA, PA 19102 USA
关键词
D O I
10.1126/science.1350379
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A parkinsonian syndrome can be produced in nonhuman primates by administration of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Parkinsonian-like symptoms induced acutely by MPTP were ameliorated after treatment with G(M1) ganglioside, a substance shown to have neurotrophic effects on the damaged dopamine system in rodents. Treatment with G(M)1 ganglioside also increased striatal dopamine and metabolite levels and enhanced the dopaminergic innervation of the striatum as demonstrated by tyrosine hydroxylase immunohistochemistry. These results suggest that G(M1) ganglioside may hold promise as a therapeutic agent for the treatment of Parkinson's disease.
引用
收藏
页码:843 / 846
页数:4
相关论文
共 36 条
[1]   GANGLIOSIDES INCREASE THE SURVIVAL OF LESIONED NIGRAL DOPAMINE NEURONS AND FAVOR THE RECOVERY OF DOPAMINERGIC SYNAPTIC FUNCTION IN STRIATUM OF RATS BY COLLATERAL SPROUTING [J].
AGNATI, LF ;
FUXE, K ;
CALZA, L ;
BENFENATI, F ;
CAVICCHIOLI, L ;
TOFFANO, G ;
GOLDSTEIN, M .
ACTA PHYSIOLOGICA SCANDINAVICA, 1983, 119 (04) :347-363
[2]   DEVELOPMENTAL TIME COURSE IN HUMAN INFANTS AND INFANT MONKEYS, AND THE NEURAL BASES OF, INHIBITORY CONTROL IN REACHING [J].
DIAMOND, A .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 608 :637-676
[3]   EFFECTS OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) ON CATECHOLAMINES AND METABOLITES IN PRIMATE BRAIN AND CSF [J].
ELSWORTH, JD ;
DEUTCH, AY ;
REDMOND, DE ;
SLADEK, JR ;
ROTH, RH .
BRAIN RESEARCH, 1987, 415 (02) :293-299
[4]   RELATION BETWEEN BRAIN DOPAMINE LOSS AND D2 DOPAMINE RECEPTOR DENSITY IN MPTP MONKEYS [J].
FALARDEAU, P ;
BEDARD, PJ ;
DIPAOLO, T .
NEUROSCIENCE LETTERS, 1988, 86 (02) :225-229
[5]   UPTAKE, CELL PENETRATION AND METABOLIC PROCESSING OF EXOGENOUSLY ADMINISTERED GM1 GANGLIOSIDE IN RAT-BRAIN [J].
GHIDONI, R ;
FIORILLI, A ;
TRINCHERA, M ;
VENERANDO, B ;
CHIGORNO, V ;
TETTAMANTI, G .
NEUROCHEMISTRY INTERNATIONAL, 1989, 15 (04) :455-465
[6]   GM1 GANGLIOSIDE-INDUCED RECOVERY OF NIGROSTRIATAL DOPAMINERGIC-NEURONS AFTER MPTP - AN IMMUNOHISTOCHEMICAL STUDY [J].
HADJICONSTANTINOU, M ;
MARIANI, AP ;
NEFF, NH .
BRAIN RESEARCH, 1989, 484 (1-2) :297-303
[7]  
HADJICONSTANTINOU M, 1986, NEUROPHARMACOLOGY, V25, P1075
[8]  
Hornykiewicz O., 1986, ADV NEUROL, V45, P19
[9]   UNEVEN PATTERN OF DOPAMINE LOSS IN THE STRIATUM OF PATIENTS WITH IDIOPATHIC PARKINSONS-DISEASE - PATHOPHYSIOLOGIC AND CLINICAL IMPLICATIONS [J].
KISH, SJ ;
SHANNAK, K ;
HORNYKIEWICZ, O .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (14) :876-880
[10]  
KOFMAN OS, 1991, J CAN SCI NEUROL, V18, P83